Page 11 - Program Strategic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Vice President would be a pretty good one. Well see. We had a meeting with the Vice President and two cochairs and well see where that leads. But theres a lot of work to be done. Fortunately the panel provide a recommendation to further enhance our abilities to prevent, and respond and protect against a buy logical incident. Today we have the opportunity to discuss recommendations with the heads of several agencies, senior people in several agencies who will be responsible for implementing some of the recommendations of the earlier panel. Im eager to hear your thoughts and hear how you bel...

Arrangement, and are you guaranteeing what is the price of the drug when are you saying you are only going to get paid x if you reach a cure level or certain level of adherence. Theres some interference there, and its used as an excuse for those types of arrangement or getting out of those arrangements by pharmaceutical companies. The other is the fda approves the drug if it works. And they dont necessarily approve it saying whether it works better than things that have previously been approved or whether it doesnt work better than thing previously approved. And that can create some friction w...

Providing low income service. Sort of almost to make it politically good, not just politically acceptable, politically good for a company to price discriminate. I wasnt sure where you were headed with that. I cant think of what it is right now. But if they were to take samples of fingerprints that are on some of those voluntary agreements, you might find fingerprints somewhere. Thats good. I think thats great. The programs are there. Just one thing, back to yesterdays conversation. He said the one thing about the act is it allowed competition to enter. What the competition did, is before the t...

And coming up, more on the recent health and Human Services forum on pharmaceutical innovation and drug costs. Up next, senators from medicare and medicaid acting administrator andy slavit and purchasing strategies for the pharmaceutical industries. This includes manufacturers, employers, consumers, Health Insurance providers and government officials. Once again, if you will all take your seats well get started on the final panel of the day. Where as promised, well devote our discussion to outcomes based purchasing, what is the potential for those, what are the obstacles and how do we get to b...

Obamas decisions on afghanistan, including up to the decision to seek the strategic agreement with the afghans that would keep a residual force there after the end of this year. But there were two aspects of the war in afghanistan that troubled me. One was the president s suspicion of the motives of the senior military, particularly when it came to the recommendations on afghanistan. And the second was what you describe. As i told rahm when i met with him, i dont mind that the president speaks out on exit strategies and so on, but the troops need to hear from their commander, the person who is...